BANK OF AMERICA CORP /DE/ - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$213,359
+20.5%
56,444
+113.6%
0.00%
Q2 2023$177,054
+11.0%
26,426
+7.9%
0.00%
Q1 2023$159,495
+41.2%
24,500
+85.1%
0.00%
Q4 2022$112,929
+105.3%
13,239
+26.6%
0.00%
Q3 2022$55,000
-94.7%
10,454
-95.7%
0.00%
Q2 2022$1,033,000
+11.6%
243,441
-7.7%
0.00%
Q1 2022$926,000
+486.1%
263,866
+1009.8%
0.00%
Q4 2021$158,000
+393.8%
23,776
+623.6%
0.00%
Q3 2021$32,000
-96.9%
3,286
-90.1%
0.00%
Q2 2021$1,026,000
-12.1%
33,218
+24.1%
0.00%
Q1 2021$1,167,00026,7590.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders